Can-Fite BioPharma (CANF) Total Non-Current Liabilities (2013 - 2026)
Can-Fite BioPharma (CANF) recorded Total Non-Current Liabilities of $975,000 in Q2 2026, down 31.1% from $1.42 million a year earlier.
Powered by 
Analysis
Can-Fite BioPharma (CANF) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends
At the end of FY2025, Can-Fite BioPharma reported Total Non-Current Liabilities of $1.19 million, down 27.0% from FY2024.
- Annual Total Non-Current Liabilities has declined for four straight years, with a five-year compound annual growth rate of -11.4% (FY2020 to FY2025).
- Across earlier years, Total Non-Current Liabilities came in at $1.63 million in FY2024 (-5.4%), $1.73 million in FY2023 (-25.2%), $2.31 million in FY2022 (-26.5%) and $3.14 million in FY2021 (+44.1%).
- The Q2 2026 figure is the lowest quarterly Total Non-Current Liabilities since Q4 2017.
- Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 60.3% in Q3 2021, against a decline of 31.1% in Q2 2026 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Can-Fite BioPharma | 1.82 Mn | -17.88 Mn | - | 975,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 975,000.00 |
| Dec 31, 2025 | 1.19 Mn |
| Jun 30, 2025 | 1.42 Mn |
| Dec 31, 2024 | 1.63 Mn |
| Jun 30, 2024 | 1.46 Mn |
| Dec 31, 2023 | 1.73 Mn |
| Sep 30, 2023 | 1.72 Mn |
| Jun 30, 2023 | 1.93 Mn |
| Mar 31, 2023 | 2.11 Mn |
| Dec 31, 2022 | 2.31 Mn |
| Sep 30, 2022 | 2.48 Mn |
| Jun 30, 2022 | 2.70 Mn |
| Mar 31, 2022 | 2.92 Mn |
| Dec 31, 2021 | 3.14 Mn |
| Sep 30, 2021 | 3.15 Mn |
| Jun 30, 2021 | 3.37 Mn |
| Mar 31, 2021 | 3.61 Mn |
| Dec 31, 2020 | 2.18 Mn |
| Sep 30, 2020 | 1.97 Mn |
| Jun 30, 2020 | 2.14 Mn |
API Access
Can-Fite BioPharma Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CANF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();